Edward D Blair, PhD, MBA

Management Team

Edward D Blair, PhD, MBA

Dr Blair is a molecular biologist/ biochemist with 15 years experience in the pharmaceutical industry, recently as a Director of Applied Diagnostics and Surrogates at GlaxoSmithKline, and is a visiting scholar at Cambridge University.

He has been involved in all aspects of early phase drug development from target identification & routine compound screening through to pre-clinical development & Phase II clinical trials. He has developed programmes that support the strategic integration of surrogate biomarkers & diagnostics into the drug development pipe-line from candidate selection to approval & launch. His broad therapeutic area experience includes viral, respiratory, liver and neurodegenerative disease, frequently in collaboration with esteemed academic groups and he was an initial recruit to the GSK Predictive Medicine Group, where he lead pioneering work on integration of testing with influenza, herpes and hepatitis C virus drug development. He is an expert in the field of virology having published more than 30 papers, edited two books and invented 6 patents in the field.

BACK